Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Immunology/Infectious Diseases | Musculoskeletal | Rheumatology | Nephrology/Urology

Systemic Lupus Erythematosus

Arizona

Tempe : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

California

Los Angeles : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Los Angeles : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Leandro : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Leandro : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Florida

Boca Raton : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Miami : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tampa : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Georgia

Atlanta : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Augusta : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Idaho

Boise : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Illinois

Chicago : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kansas

Kansas City : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Maryland

Chevy Chase : The Center for Rheumatology and Bone Research - Chevy Chase, MD

Do you have Systemic Lupus Erythematosus?

Laurel : The Center for Rheumatology and Bone Research - Laurel, MD

Do you have Systemic Lupus Erythematosus?

Rockville : The Center for Rheumatology and Bone Research - Rockville, MD

Do you have Systemic Lupus Erythematosus?

Wheaton : The Center for Rheumatology and Bone Research - Wheaton, MD

Do you have Systemic Lupus Erythematosus?

Massachusetts

Boston : BWH - Brigham and Women's Hospital

A randomised, double-blind, placebo-controlled, multicenter prospective dose-finding Phase II/III study with atacicept given subcutaneously to subjects having recently experienced a flare of systemic lupus erythematosus (SLE)

Boston : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Minnesota

Rochester : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Missouri

St Louis : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

New York

Great Neck : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Great Neck : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Lake Success : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lake Success : Biomedical Research Alliance of New York

Belimumab in subjects with SLE - Adults

Lake Success : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults

Lake Success : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults

Manhasset : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Manhasset : Biomedical Research Alliance of New York

Belimumab in subjects with SLE

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE)

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults

Manhasset : Biomedical Research Alliance of New York

Systemic Lupus Erythematosus (SLE) - Adults and minors

New York : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

New York : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Orchard Park : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Rochester : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

North Carolina

Charlotte : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Charlotte : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Wilmington : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Wilmington : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Ohio

Cincinnati : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cincinnati : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Columbus : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Oregon

Portland : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Pennsylvania

Bethlehem : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bethlehem : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Philadelphia : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

South Carolina

Charleston : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Charleston : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Tennessee

Memphis : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Texas

Amarillo : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Amarillo : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Dallas : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Dallas : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

El Paso : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Houston : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Mesquite : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Antonio : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sugar Land : Texas Research Center, LLP

Have you been diagnosed with Systemic Lupus Erythematosus (SLE)?

Temple : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Washington

Vancouver : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Washington, DC

Washington : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Washington : The Center for Rheumatology and Bone Research - Washington, DC

Do you have Systemic Lupus Erythematosus?

Argentina

Buenos Aires : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Buenos Aires : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cordoba : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Córdoba : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Juan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Miguel De Tucuman : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Miguel De Tucuman : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Tucuman : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Brazil

Belo Horizonte : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Brasilia : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Curitiba : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Goiania : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Marilia : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Porto Alegre : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Recife : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Ribeirão Preto : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Rio De Janeiro : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sao Paulo : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bulgaria

Pleven : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sofia : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Canada

Scarborough, ON : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Toronto, ON : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Vancouver, BC : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Chile

Concepcion : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Puente Alto : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Santiago : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

China

Beijing : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Chengdu : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Chongqing : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Dalian : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Guangzhou : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Harbin : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Hong Kong : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Jinan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kunming : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Nanning : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Shanghai : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Shenyan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Shenyang : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Wuhan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Colombia

Barranquilla : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Barranquilla : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bogota : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bogota : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bucaramanga : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Medellin : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Medellin : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Costa Rica

San José : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

France

Bordeaux : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Creteil : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Le Kremlin-Bicetre : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lille : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lille : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Paris : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Strasbourg : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Strasbourg : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Toulouse : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Germany

Aachen : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bad Abbach : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bad Bramstedt : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Berlin : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Dresden : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Düsseldorf : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Erlangen : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Freiburg : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Hamburg : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Hannover : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Heidelberg : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tübingen : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Hungary

Budapest : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Budapest : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Debrecen : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Debrecen : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Miskolc : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Pécs : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Pécs : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Szeged : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Szombathely : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Zalaegerszeg : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Indonesia

Jakarta : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Malang : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Medan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Malaysia

Johor Bahru : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kuala Lumpur : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kuching : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kuching : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Mexico

Chihuahua : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Culiacan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Guadalajara : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Mexico City : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Obregon : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Luis Potosi : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Netherlands

Amsterdam : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Peru

Callao : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lima : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Philippines

Cebu City : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cebu City : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Iloilo City : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Manila : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Quezon City : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Poland

Bydgoszcz : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Krakow : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lodz : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lublin : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Szczecin : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Warszawa : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Wroclaw : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Portugal

Almada : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lisboa : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Porto : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Romania

Bucharest : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Iasi : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Russian Federation

Kazan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Moscow : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Ryazan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

St Petersburg : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Yaroslavl : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Singapore

Singapore : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Singapore : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

South Africa

Cape Town : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cape Town : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Durban : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Durban : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Spain

Barcelona : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Madrid : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Malaga : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sevilla : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sevilla : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Sweden

Huddinge : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lund : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Stockholm : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Uppsala : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Taiwan

Chia-Yi : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kaohsiung : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Taichung : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Taoyuan : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Thailand

Bangkok : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bangkok : Research Site:

A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Chiang Mai : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Khon Kaen : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Phitsanulok : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Songkhla : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Turkey

Adana : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Ankara : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Istanbul : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Izmir : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

United Kingdom

Birmingham : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cambridge : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Derby : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Leeds : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

London : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Manchester : Research Site:

A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.